We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Según presenta un afiche, la implantación bilateral de ...
Without presbyopia-correcting IOLs, most patients undergoing cataract surgery experience poor near vision requiring vision correction such as reading glasses or contact lenses. The AcrySof IQ ReSTOR ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — Bilateral implantation of an apodized ...
Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...
SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...
GAITHERSBURG, Maryland — The ophthalmic devices advisory committee voted 12-0 that the benefits of the Acrysof IQ ReSTOR intraocular lens made by Alcon (Fort Worth, Texas), outweigh the risks, thus ...
The US Food and Drug Administration (FDA) has approved a new intraocular lens (IOL) designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults. The ...
The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses This ...
Novartis International AG / Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS design for uncompromised distance vision and presbyopia correction .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results